Early Adoption of Checkpoint Inhibitors in Patients with Metastatic Gastric Adenocarcinoma—A Case Series of Non-Operative Long-Term Survivors

Checkpoint inhibitor (CPI) therapy has only recently been introduced in the first-line treatment of advanced gastric cancer. However, later line monotherapy CPI efficacy in a subset of patients was presented about four years prior. Here, we present three cases of advanced gastric adenocarcinoma canc...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaakour, Dalia, Ward, Garrett, Dayyani, Farshid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149843/
https://www.ncbi.nlm.nih.gov/pubmed/35645245
http://dx.doi.org/10.3390/diseases10020024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149843/
https://www.ncbi.nlm.nih.gov/pubmed/35645245
http://dx.doi.org/10.3390/diseases10020024

Ejemplares similares